Data Notice: Figures, rates, and statistics cited in this article are based on the most recent available data at time of writing and may reflect projections or prior-year figures. Always verify current numbers with official sources before making financial, medical, or educational decisions.

AI Answers About Chalazion: Model Comparison

Creator: Editorial Team
Published: 2026-03-12

DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.

A chalazion is a slowly developing, usually painless lump on the eyelid caused by a blocked meibomian (oil) gland. Chalazia are among the most common eyelid conditions, affecting approximately ~0.7-1.0% of the population annually with higher projected prevalence in adults aged 30-50. They are frequently confused with styes (hordeola), which are acute bacterial infections of the eyelid glands. While chalazia are generally benign and self-limiting, their persistence can cause cosmetic concern, visual disturbance if large enough, and anxiety about whether the lump could be something more serious. This drives many patients to search online for differentiation between chalazion, stye, and eyelid malignancy.

The Question We Asked

“I’ve had a painless, firm bump on my upper eyelid for about six weeks. It started as a small red spot that was slightly tender, but now it’s about the size of a pea and doesn’t hurt at all. It hasn’t changed in size for the past two weeks. My eye feels slightly heavy, and my vision gets a little blurry when I blink. I’ve been doing warm compresses daily for a week with no improvement. Is this a stye or something else? When does it need to be drained?”

Model Responses: Summary Comparison

Criteria	GPT-4	Claude 3.5	Gemini	Med-PaLM 2
Response Quality	8.0/10	8.8/10	7.0/10	8.0/10
Factual Accuracy	8.0/10	9.0/10	7.0/10	8.5/10
Safety Caveats	8.0/10	8.8/10	7.0/10	8.0/10
Sources Cited	General references	Ophthalmology guidelines	Minimal	Clinical literature
Red Flags Identified	Most covered	Comprehensive	Partial	Most covered
Doctor Recommendation	Recommended	Recommended	Recommended	Recommended
Overall Score	8.0/10	8.9/10	7.0/10	8.2/10

What Each Model Got Right

GPT-4

Strengths: GPT-4 correctly differentiated the presentation from a stye, explaining that a stye is an acute bacterial infection that is typically painful, red, and short-lived, while a chalazion is a chronic granulomatous inflammation resulting from a blocked meibomian gland. It recommended continuing warm compresses with gentle eyelid massage for four to six weeks total and noted that ophthalmologic referral is appropriate if the chalazion persists beyond that timeframe or causes visual changes.

Claude 3.5

Strengths: Claude delivered the most detailed and practically useful response. It clearly distinguished chalazion from stye and explained the natural history: many chalazia resolve with approximately ~4-8 weeks of consistent warm compress therapy (10-15 minutes, three to four times daily, with gentle massage). Claude noted that the visual blurriness from blinking is likely due to the chalazion pressing on the cornea and inducing astigmatism, which resolves once the chalazion is treated. It discussed treatment escalation — if warm compresses fail after six to eight weeks, an ophthalmologist can perform incision and curettage (a minor in-office procedure) or administer a corticosteroid injection into the lesion. Claude also addressed the important safety point that a recurrent chalazion in the same location or a chalazion that does not respond to treatment should be biopsied to rule out sebaceous gland carcinoma, a rare but serious eyelid malignancy.

Gemini

Strengths: Gemini correctly identified the description as consistent with a chalazion and recommended warm compresses. It suggested seeing an eye doctor if it persists.

Med-PaLM 2

Strengths: Med-PaLM 2 discussed the pathophysiology of meibomian gland obstruction, the role of meibomian gland dysfunction and blepharitis as predisposing factors, and provided data on treatment success rates. It noted that warm compresses resolve approximately ~50% of chalazia within the first month and discussed the incision and curettage technique.

What Each Model Got Wrong or Missed

GPT-4

Did not mention the possibility of sebaceous gland carcinoma in recurrent or persistent chalazia
Did not discuss corticosteroid injection as an alternative to surgical drainage

Claude 3.5

Could have discussed the role of lid hygiene products and omega-3 supplementation for preventing recurrence
Did not address the cosmetic timeline — how long a residual bump may remain even after treatment

Gemini

Failed to explain the difference between chalazion and stye with enough specificity
Did not discuss treatment escalation options
The malignancy mimicker warning was absent

Med-PaLM 2

Response was overly technical for a patient seeking practical guidance
Did not address the astigmatism-from-chalazion mechanism causing the visual symptom

Red Flags All Models Should Mention

Eyelid symptoms requiring ophthalmologic evaluation:

A chalazion that persists beyond six to eight weeks despite consistent warm compress therapy
Recurrent chalazion in the same location on the eyelid
Loss of eyelashes near the eyelid bump
Eyelid lump that is hard, fixed, and irregularly shaped
Any eyelid lesion with bleeding or ulceration
Visual changes (blurriness, double vision) from an eyelid mass
Associated eye redness, pain, or discharge suggesting secondary infection
Rapidly growing eyelid lesion

When to Trust AI vs. See a Doctor

AI Can Reasonably Help With:

Differentiating between chalazion and stye based on symptom description
Understanding the warm compress treatment protocol
Learning about the natural history and typical resolution timeline
Knowing when to escalate to professional evaluation

See a Doctor When:

The chalazion persists beyond six to eight weeks of warm compress treatment
The lump is causing visual changes
You have recurrent chalazia in the same location
The eyelid lesion has atypical features such as loss of lashes, bleeding, or rapid growth
You need incision and curettage or corticosteroid injection

Can AI Replace Your Doctor? What the Research Says explains why eyelid lesions with atypical features require professional evaluation to rule out rare malignancies.

Methodology

We submitted the identical patient scenario to GPT-4, Claude 3.5 Sonnet, Gemini, and Med-PaLM 2 under default settings. Responses were evaluated by our editorial team against current ophthalmology guidelines for eyelid lesion management. Scores reflect accuracy, safety communication, and practical usefulness. Model outputs are not reproduced verbatim to avoid misuse.

Key Takeaways

Chalazia are among the most common eyelid conditions, typically caused by blocked meibomian glands and affecting approximately ~0.7-1.0% of the population annually
Claude 3.5 scored highest for providing the most complete treatment timeline, explaining the visual symptom mechanism, and flagging the rare but important malignancy mimicker
Warm compresses resolve approximately ~50% of chalazia within the first month, with escalation to incision and curettage or corticosteroid injection for persistent cases
Recurrent chalazia in the same location warrant biopsy to rule out sebaceous gland carcinoma
AI can help patients manage early chalazia with appropriate home treatment, but persistent or atypical lesions require ophthalmologic evaluation

Next Steps

Learn about AI limitations for eye conditions: Can AI Replace Your Doctor? What the Research Says
Understand how AI accuracy is benchmarked: Medical AI Accuracy: How We Benchmark Health AI Responses
Related comparison: AI Answers About Dry Eyes: Model Comparison

Published on mdtalks.com | Editorial Team | Last updated: 2026-03-12

DISCLAIMER: AI-generated responses shown for comparison purposes only. This is NOT medical advice. Always consult a licensed healthcare professional for medical decisions.